Gilead Sciences, Inc. (BMV:GILD)
2,075.01
0.00 (0.00%)
At close: Oct 10, 2025
Gilead Sciences Revenue
Gilead Sciences had revenue of $7.05B USD in the quarter ending June 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to $28.72B, up 3.96% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.61B with 6.22% growth.
Revenue (ttm)
$28.72B
Revenue Growth
+3.96%
P/S Ratio
4.95
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
2,696.49B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.61B | 1.68B | 6.22% |
Dec 31, 2023 | 26.93B | -48.00M | -0.18% |
Dec 31, 2022 | 26.98B | -26.00M | -0.10% |
Dec 31, 2021 | 27.01B | 2.65B | 10.89% |
Dec 31, 2020 | 24.36B | 2.24B | 10.11% |
Dec 31, 2019 | 22.12B | 442.00M | 2.04% |
Dec 31, 2018 | 21.68B | -3.99B | -15.53% |
Dec 31, 2017 | 25.66B | -4.29B | -14.33% |
Dec 31, 2016 | 29.95B | -2.20B | -6.84% |
Dec 31, 2015 | 32.15B | 7.68B | 31.37% |
Dec 31, 2014 | 24.47B | 13.67B | 126.53% |
Dec 31, 2013 | 10.80B | 1.41B | 14.96% |
Dec 31, 2012 | 9.40B | 1.01B | 12.08% |
Dec 31, 2011 | 8.39B | 435.97M | 5.48% |
Dec 31, 2010 | 7.95B | 938.04M | 13.38% |
Dec 31, 2009 | 7.01B | 1.68B | 31.40% |
Dec 31, 2008 | 5.34B | 1.11B | 26.14% |
Dec 31, 2007 | 4.23B | 1.20B | 39.78% |
Dec 31, 2006 | 3.03B | 997.74M | 49.19% |
Dec 31, 2005 | 2.03B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition